RXRX
Recursion Pharmaceuticals Inc - Class A
$3.54
+10.97% (+$0.35)
Volume
28.18M
52W High
$7.18
52W Low
$2.77
Market Cap
$1.76B
What to Watch This Quarter
Based on historical dataConsensus EPS
-$0.24
Whisper EPS
-$0.24
1.2% above consensus
Last Quarter
-$0.25
Current Streak
2 Misss
Avg Surprise (4Q)
+3.63%
Next Earnings Report
Reports in 46 days
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q2 2026
Aug 5, 2026
1-Day:
+0.32%
5-Day:
+3.79%
Q2 2026
Aug 4, 2026
1-Day:
-4.23%
Q1 2026
May 11, 2026
1-Day:
-3.37%
Q1 2026
May 6, 2026
1-Day:
-4.66%
5-Day:
-4.96%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $35.5M | +687.8% | 24.4% | -304.8% | -$108.1M |
| Q3'25 | $5.2M | -80.2% | -471.9% | -3,327.6% | -$162.3M |
| Q2'25 | $19.1M | +32.6% | -5.5% | -922.5% | -$171.9M |
| Q1'25 | $14.7M | +9.3% | -48.0% | -1,297.9% | -$202.5M |
| Q4'24 | $4.5M | -57.5% | -183.6% | -4,073.8% | -$178.9M |
| Q3'24 | $26.1M | +158.2% | 53.7% | -377.1% | -$95.7M |
| Q2'24 | $14.4M | +30.8% | 36.1% | -698.0% | -$97.5M |
| Q1'24 | $13.5M | +11.2% | 17.2% | -714.1% | -$91.4M |
Company Information
Symbol
RXRX
Company
Recursion Pharmaceuticals Inc - Class A
Market Cap
$1.76B
Next Earnings
Nov 4, 2026